Gain Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MARSHALL WACE, LLP | 02/13/2026 | 1.66 M | $5.35 M | 849.30% | 4.75% |
| POTOMAC CAPITAL MANAGEMENT, INC. | 02/11/2026 | 1.01 M | $3.25 M | 100.00% | 2.89% |
| JONES FINANCIAL COMPANIES LLLP | 02/17/2026 | 702.21 K | $2.26 M | 3.75% | 2.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 684.35 K | $2.20 M | 750.81% | 1.96% |
| VANGUARD GROUP INC | 01/29/2026 | 569.90 K | $1.84 M | 6.65% | 1.63% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 568.65 K | $1.83 M | 78.46% | 1.62% |
| DME CAPITAL MANAGEMENT, LP | 02/17/2026 | 566.13 K | $1.82 M | 0.00% | 1.62% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 397.94 K | $1.28 M | 15.63% | 1.14% |
| JANE STREET GROUP, LLC | 02/12/2026 | 242.33 K | $780.30 K | 234.48% | 0.69% |
| BLACKROCK, INC. | 02/12/2026 | 209.58 K | $674.84 K | 80.39% | 0.60% |
| CRESSET ASSET MANAGEMENT, LLC | 02/17/2026 | 160.00 K | $515.20 K | 100.00% | 0.46% |
| STATE STREET CORP | 02/13/2026 | 157.54 K | $507.27 K | 72.86% | 0.45% |
| MORGAN STANLEY | 02/13/2026 | 147.59 K | $475.24 K | -5.19% | 0.42% |
| LPL FINANCIAL LLC | 02/11/2026 | 106.55 K | $343.09 K | 100.00% | 0.30% |
| NORTHERN TRUST CORP | 02/17/2026 | 102.00 K | $328.44 K | 15.39% | 0.29% |
| UBS GROUP AG | 01/29/2026 | 81.12 K | $261.21 K | -42.34% | 0.23% |
| COLONY GROUP, LLC | 02/13/2026 | 77.86 K | $250.69 K | 100.00% | 0.22% |
| HRT FINANCIAL LP | 02/12/2026 | 55.68 K | $179.00 K | 182.39% | 0.16% |
| GROUP ONE TRADING, L.P. | 02/12/2026 | 54.16 K | $174.39 K | 222.86% | 0.15% |
| CITADEL ADVISORS LLC | 02/17/2026 | 51.40 K | $165.51 K | 399.03% | 0.15% |
| SIMPLEX TRADING, LLC | 02/11/2026 | 47.95 K | $154.39 K | 100.00% | 0.14% |
| BENEDICT FINANCIAL ADVISORS INC | 01/27/2026 | 38.00 K | $122.36 K | 8.57% | 0.11% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 37.30 K | $120.11 K | 100.00% | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 02/17/2026 | 35.82 K | $115.34 K | 0.00% | 0.10% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 32.49 K | $104.63 K | 100.00% | 0.09% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 32.48 K | $104.59 K | 100.00% | 0.09% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 30.60 K | $98.53 K | 100.00% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 30.00 K | $96.61 K | 0.00% | 0.09% |
| CITADEL ADVISORS LLC | 02/17/2026 | 26.10 K | $84.04 K | 100.00% | 0.07% |
| LIGHTHOUSE INVESTMENT PARTNERS, LLC | 02/17/2026 | 23.04 K | $74.19 K | 100.00% | 0.07% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 20.47 K | $66.00 K | 100.00% | 0.06% |
| OLIVER LUXXE ASSETS LLC | 01/08/2026 | 20.25 K | $65.21 K | 100.00% | 0.06% |
| APOLLON WEALTH MANAGEMENT, LLC | 01/22/2026 | 19.83 K | $63.84 K | 100.00% | 0.06% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 17.40 K | $56.03 K | -86.20% | 0.05% |
| WEALTHSPIRE ADVISORS, LLC | 02/13/2026 | 16.90 K | $54.42 K | 100.00% | 0.05% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/08/2026 | 15.56 K | $39.67 K | 0.00% | 0.04% |
| SANDHILL CAPITAL PARTNERS LLC | 02/12/2026 | 15.40 K | $49.59 K | 0.00% | 0.04% |
| ENGINEERS GATE MANAGER LP | 02/17/2026 | 14.62 K | $47.07 K | 100.00% | 0.04% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 14.00 K | $45.09 K | 100.00% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 14.00 K | $45.08 K | 100.00% | 0.04% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/12/2026 | 12.69 K | $40.85 K | 100.00% | 0.04% |
| SPROTT INC. | 02/12/2026 | 12.00 K | $38.64 K | 100.00% | 0.03% |
| KESTRA ADVISORY SERVICES, LLC | 02/13/2026 | 12.00 K | $38.64 K | 0.00% | 0.03% |
| NEWEDGE ADVISORS, LLC | 02/18/2026 | 10.60 K | $34.13 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 6.86 K | $22.09 K | 232.32% | 0.02% |
| MAI CAPITAL MANAGEMENT | 02/13/2026 | 4.41 K | $14.20 K | 0.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 3.91 K | $12.58 K | 0.03% | 0.01% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 2.65 K | $8.53 K | 0.00% | 0.01% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2.38 K | $7.67 K | 100.00% | 0.01% |
| FNY INVESTMENT ADVISERS, LLC | 01/16/2026 | 2.00 K | $6.00 K | 100.00% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Gain Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 66 institutional investors and hedge funds held shares of Gain Therapeutics Inc. The most heavily invested institutionals were:
Cambridge Investment Research Advisors, Inc.: 568,645
GSA CAPITAL PARTNERS LLP: 312,467
VANGUARD FIDUCIARY TRUST CO: 229,979
UBS Group AG: 220,489
JANE STREET GROUP, LLC: 216,883
Stratos Wealth Partners, LTD.: 131,621
23.03% of Gain Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 9.65 M shares in the last 24 months. This purchase volume represents approximately $28.27 M in transactions.